Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence
Sofosbuvir for hepatitis C works well despite multiple negative predictive factors
People living with HIV in the UK still have impaired health-related quality of life
Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6
'Chem sex' commonly reported by UK gay men diagnosed with shigella
BMS combination cures 90% of genotype 1b hepatitis C in 24 weeks
Sofosbuvir + ribavirin is safe and effective for people with hepatitis C who have advanced liver disease
Abolishing HIV in Rwanda
Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B
